Linking immunity to atherosclerosis: Implications for vascular pharmacology - A tribute to Göran K. Hansson

Vascular Pharmacology

Volumn 56, Issue 1-2, 2012, Pages 29-33

  Geng, Yong Jian ^a   Jonasson, Lena ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Antibody; Atherosclerosis; Immunity; Immunotherapy; Inflammation; Lymphocytes; Macrophages

Indexed keywords

APOLIPOPROTEIN B100; CHOLERA TOXIN B SUBUNIT; CYCLOSPORIN A; CYTOKINE; DENDRITIC CELL VACCINE; GAMMA INTERFERON; HLA DR ANTIGEN; IMMUNOMODULATING AGENT; INTERLEUKIN 18; INTERLEUKIN 2 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 10; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROSCLEROSIS; BRAIN INFARCTION; CAROTID ATHEROSCLEROSIS; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL MEDICINE; CLINICAL PHARMACOLOGY; CYTOKINE PRODUCTION; DRUG INHIBITION; EVIDENCE BASED MEDICINE; HEART INFARCTION; HUMAN; IMMUNE DEFICIENCY; IMMUNIZATION; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; NONHUMAN; PATHOGENESIS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SMOOTH MUSCLE FIBER; T LYMPHOCYTE ACTIVATION; TREATMENT INDICATION; VACCINATION; VASCULAR ENDOTHELIUM; VASCULAR PHARMACOLOGY; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL;

ANIMALS; ATHEROSCLEROSIS; BLOOD VESSELS; HUMANS; IMMUNITY; IMMUNOTHERAPY; INFLAMMATION;

EID: 84856297633     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2011.11.001     Document Type: Review

References (47)

1. Brown M.S., Goldstein J.L. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 1983, 52:223-261.
2. Caligiuri G., Paulsson G., Nicoletti A., Maseri A., Hansson G.K. Evidence for antigen-driven T-cell response in unstable angina. Circulation 2000, 102:1114-1119.
3. Caligiuri G., Nicoletti A., Poirier B., Hansson G.K. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J. Clin. Invest. 2002, 109:745-753.
4. Elhage R., Jawien J., Rudling M., Ljunggren H.G., Takeda K., Akira S., Bayard F., Hansson G.K. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc. Res. 2003, 59:234-240.
5. Fazio S., Linton M.F. The inflamed plaque: cytokine production and cellular cholesterol balance in the vessel wall. Am. J. Cardiol. 2001, 88:12E-15E.
6. Geng Y.J. Regulation of programmed cell death or apoptosis in atherosclerosis. Heart Vessels Suppl. 1997, 12:76-80.
7. Geng Y.J., Hansson G.K. Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J. Clin. Invest. 1992, 89:1322-1330.
8. Geng Y.J., Hansson G.K. High endothelial cells of postcapillary venules express the scavenger receptor in human peripheral lymph nodes. Scand. J. Immunol. 1995, 42:289-296.
9. Geng Y., Hansson G.K., Holme E. Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ. Res. 1992, 71:1268-1276.
10. Geng Y.J., Almqvist M., Hansson G.K. cDNA cloning and expression of inducible nitric oxide synthase from rat vascular smooth muscle cells. Biochim. Biophys. Acta 1994, 1218:421-424.
11. Geng Y.J., Petersson A.S., Wennmalm A., Hansson G.K. Cytokine-induced expression of nitric oxide synthase results in nitrosylation of heme and nonheme iron proteins in vascular smooth muscle cells. Exp. Cell Res. 1994, 214:418-428.
12. Geng Y.J., Holm J., Nygren S., Bruzelius M., Stemme S., Hansson G.K. Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T-cell cytokine interferon-gamma. Arterioscler. Thromb. Vasc. Biol. 1995, 15:1995-2002.
13. Geng Y.J., Hellstrand K., Wennmalm A., Hansson G.K. Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to gamma-interferon and tumor necrosis factor-alpha. Cancer Res. 1996, 56:866-874.
14. Goldstein J.L., Kita T., Brown M.S. Defective lipoprotein receptors and atherosclerosis. Lessons from an animal counterpart of familial hypercholesterolemia. N Engl J. Med. 1983, 309:288-296.
15. Hansson G.K. Immune and inflammatory mechanisms in the development of atherosclerosis. Br. Heart J. 1993, 69:S38-S41.
16. Hansson G.K. Immunological control mechanisms in plaque formation. Basic Res. Cardiol. 1994, 89(Suppl. 1):41-46.
17. Hansson G.K., Hermansson A. The immune system in atherosclerosis. Nat. Immunol. 2011, 12:204-212.
18. Hansson G.K., Jonasson L., Holm J., Claesson-Welsh L. Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain. Clin. Exp. Immunol. 1986, 64:261-268.
19. Hansson G.K., Jonasson L., Holm J., Clowes M.M., Clowes A.W. Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro. Circ. Res. 1988, 63:712-719.
20. Hansson G.K., Holm J., Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 1989, 135:169-175.
21. Hansson G.K., Geng Y.J., Holm J., Hardhammar P., Wennmalm A., Jennische E. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J. Exp. Med. 1994, 180:733-738.
22. Hansson G.K., Robertson A.K., Soderberg-Naucler C. Inflammation and atherosclerosis. Annu. Rev. Pathol. 2006, 1:297-329.
23. Harvey E.J., Ramji D.P. Interferon-gamma and atherosclerosis: pro- or anti-atherogenic?. Cardiovasc. Res. 2005, 67:11-20.
24. Hermansson A., Johansson D.K., Ketelhuth D.F., Andersson J., Zhou X., Hansson G.K. Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice. Circulation 2011, 123:1083-1091.
25. Jonasson L., Holm J., Skalli O., Gabbiani G., Hansson G.K. Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J. Clin. Invest. 1985, 76:125-131.
26. Jonasson L., Holm J., Skalli O., Bondjers G., Hansson G.K. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986, 6:131-138.
27. Jonasson L., Holm J., Hansson G.K. Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:2303-2306.
28. Jonasson L., Holm J., Hansson G.K. Smooth muscle cells express Ia antigens during arterial response to injury. Lab. Investig. 1988, 58:310-315.
29. Klingenberg R., Lebens M., Hermansson A., Fredrikson G.N., Strodthoff D., Rudling M., Ketelhuth D.F., Gerdes N., Holmgren J., Nilsson J., Hansson G.K. Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2010, 30:946-952.
30. Leon M.L., Zuckerman S.H. Gamma interferon: a central mediator in atherosclerosis. Inflamm. Res. 2005, 54:395-411.
31. Libby P., Aikawa M. New insights into plaque stabilisation by lipid lowering. Drugs 1998, 56(Suppl. 1):9-13. discussion 33.
32. Libby P., Ridker P.M., Hansson G.K. Progress and challenges in translating the biology of atherosclerosis. Nature 2011, 473:317-325.
33. Nicoletti A., Kaveri S., Caligiuri G., Bariety J., Hansson G.K. Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J. Clin. Invest. 1998, 102:910-918.
34. Nicoletti A., Paulsson G., Caligiuri G., Zhou X., Hansson G.K. Induction of neonatal tolerance to oxidized lipoprotein reduces atherosclerosis in ApoE knockout mice. Mol. Med. 2000, 6:283-290.
35. Nilsson J., Hansson G.K., Shah P.K. Immunomodulation of atherosclerosis: implications for vaccine development. Arterioscler. Thromb. Vasc. Biol. 2005, 25:18-28.
36. Ovchinnikova O., Robertson A.K., Wagsater D., Folco E.J., Hyry M., Myllyharju J., Eriksson P., Libby P., Hansson G.K. T-cell activation leads to reduced collagen maturation in atherosclerotic plaques of Apoe(-/-) mice. Am. J. Pathol. 2009, 174:693-700.
37. Paulsson G., Zhou X., Tornquist E., Hansson G.K. Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2000, 20:10-17.
38. Robertson A.K., Rudling M., Zhou X., Gorelik L., Flavell R.A., Hansson G.K. Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J. Clin. Invest. 2003, 112:1342-1350.
39. Ross R. Atherosclerosis: the role of endothelial injury, smooth muscle proliferation and platelet factors. Triangle 1976, 15:45-51.
40. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
41. Stemme S., Holm J., Hansson G.K. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler. Thromb. 1992, 12:206-211.
42. Stemme S., Faber B., Holm J., Wiklund O., Witztum J.L., Hansson G.K. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:3893-3897.
43. Virchow, R., 1858. Cellular, Pathology. pp 355.
44. Zhou X., Stemme S., Hansson G.K. Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. Am. J. Pathol. 1996, 149:359-366.
45. Zhou X., Nicoletti A., Elhage R., Hansson G.K. Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000, 102:2919-2922.
46. Zhou X., Caligiuri G., Hamsten A., Lefvert A.K., Hansson G.K. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2001, 21:108-114.
47. Zhou X., Robertson A.K., Hjerpe C., Hansson G.K. Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2006, 26:864-870.